(Reuters) – UK’s competition regulator said on Monday it has cleared U.S. medical equipment maker Thermo Fisher Scientific’s $3.1 billion deal to buy Swedish biotech firm Olink Holding AB.
(Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Shinjini Ganguli)
